Nova Eye Medical (EYE) Discussion, page-755

Agreed, I've certainly been taking the opportunity to purchase more shares as I am very confident that iTrack Advance will be a strong performer and that 2RT will achieve a partnership in the near term. All the feedback from early iTrack Advance users has been extremely positive

The sales update will include sales for the half year through to June 30. This means it will include the very early adoption, but most of it will be pre-FDA approval. We need to wait for 1H FY24 (December) to properly understand what uptake is like. Im hoping they include guidance though as this will help the market better price this company.

Of course there's still 2RT, which is where any major share price rerate is most likely to come from. A partnership announcement could come any day, and depending on what terms of the arrangement are this could be a massive catalyst event. iTrack Advance will likely deliver slower but sustained share price growth rather than a sudden and sharp rerate imo